Institutional Ownership
Better Therapeutics Inc Common
CUSIP 08773T104COMBTTXQ1 2026
13D / 13G Filings
13
Schedule 13D/13G on record
Beneficial Filers
7
Distinct reporting persons
Largest Stake
44.3%
Max % of class reported
Institutional Holders
1
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
13 filings · latest Feb 13, 2024
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 13, 2024 | Mmcap International Inc. Spc | 13G/A | 0.7% | 356.3K | SEC |
| 2 | Feb 12, 2024 | David P. Perry 2015 Trust | 13D/A | 28.4% | 15.48M | SEC |
| 3 | Jan 25, 2024 | David P. Perry 2015 Trust | 13D/A | 28.4% | 14.64M | SEC |
| 4 | Aug 14, 2023 | David P. Perry 2015 Trust | 13D/A | 32.5% | 13.16M | SEC |
| 5 | Jul 31, 2023 | Mmcap International Inc. Spc | 13G | 9.5% | 3.86M | SEC |
| 6 | Apr 21, 2023 | David P. Perry 2015 Trust | 13D/A | 37.5% | 11.91M | SEC |
| 7 | Apr 13, 2023 | Mountain Crest Capital LLC | 13G/A | 4.4% | 1.39M | SEC |
| 8 | Feb 7, 2023 | Farallon Capital Partners, L.P. | 13G/A | 0.3% | 75.1K | SEC |
| 9 | Feb 10, 2022 | Rpo LLC | 13G/A | — | — | SEC |
| 10 | Feb 9, 2022 | Farallon Capital Management LLC | 13G/A | 0.5% | 124.1K | SEC |
3 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Better Therapeutics Inc Common.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Ancora Advisors LLC | 3.0K | $0 |